Solvent detergent vs. fresh frozen plasma in cirrhotic patients undergoing liver transplant surgery: A prospective randomized control study

Vox Sanguinis

Volumn 105, Issue 2, 2013, Pages 137-143

  Bindi, M L ^a   Miccoli, M ^b   Marietta, M ^c   Meacci, L ^a   Esposito, M ^a   Bisa M ^a   Mozzo, R ^a   Mazzoni, A ^a   Baggiani, A ^b   Scatena, F ^a   Filipponi, F ^b   Biancofiore, G ^a  

^a UNIVERSITY HOSPITAL OF PISA   (Italy)

^b UNIVERSITY OF PISA   (Italy)

^c UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Blood transfusion; Liver transplantation; Thromboelastography

Indexed keywords

BLOOD CLOTTING FACTOR 12; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 8; DETERGENT; FRESH FROZEN PLASMA; PLASMASAFE; SOLVENT DETERGENT; UNCLASSIFIED DRUG; VITRONECTIN;

ADULT; ARTICLE; BLOOD CLOTTING TEST; FEMALE; HUMAN; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PLASMA TRANSFUSION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL (TOPIC); THROMBOELASTOGRAPHY;

BLOOD TRANSFUSION; LIVER TRANSPLANTATION; THROMBOELASTOGRAPHY;

ADULT; ALLOGRAFTS; BLOOD COMPONENT TRANSFUSION; BLOOD PROTEINS; DETERGENTS; FEMALE; HUMANS; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PLASMA; SOLVENTS; THROMBELASTOGRAPHY;

EID: 84880298407     PISSN: 00429007     EISSN: 14230410     Source Type: Journal    
DOI: 10.1111/vox.12021     Document Type: Article

References (35)

1. Biancofiore G, Niemann CU: Liver transplant perioperative pathways: which way towards high-quality care and better outcomes? Minerva Anestesiol 2010; 76:769-770
2. De Boer MT, Christensen MC, Asmussen M, et al.: The impact of intraoperative transfusion of platelets and red blood cells on survival after liver transplantation. Anesth Analg 2008; 106:32-44
3. Massicotte L, Sassine MP, Lenis S, et al.: Survival rate changes with transfusion of blood products during liver transplantation. Can J Anaesth 2005; 52:148-155
4. Sihler KC, Napolitano LM: Complication of massive Transfusion. Chest 2010; 137:209-220
5. Mangus RS, Kinsella SB, Nobari MM, et al.: Predictors of blood product use in orthotopic liver transplantation using the piggyback hepatectomy technique. Transplant Proc 2007; 39:3207-3213
6. Massiccotte L, Lenis S, Thibeault L, et al.: Effect of low central venous pressure and phlebotomy on blood product transfusion requirements during liver transplantation. Liver Transpl 2006; 12:117-123
7. Coakley M, Reddy K, Mackie I, et al.: Transfusion triggers in orthotopic liver transplantation: a comparison of the thromboelastometry analyzer, the thromboelastogram, and conventional coagulation tests. J Cardiothorac Vasc Anesth 2006; 20:548-553
8. Hannaman MJ, Hevesi ZG: Anesthesia care for liver transplantation. Transplant Review 2011; 25:36-43
9. Dickneite G, Pragst I: Prothrombin complex concentrate vs. fresh frozen plasma for reversal of dilutional coagulopathy in a porcine trauma model. Br J Anaesth 2009; 102:345-354
10. Massicotte L, Sassine M-P, Lenis S, et al.: Transfusion predictors in liver transplant. Anesth Analg 2004; 98:1245-1251
11. Benson AB, Burton JR, Austin GL, et al.: Differential effects of plasma and red blood cell transfusions on acute lung injury and infection risk following liver transplantation. Liver Transpl 2011; 17:149-158
12. Bux J: Antibody-mediated (immune) transfusion-related acute lung injury. Vox Sang 2011; 100:122-128
13. Stanworth SJ, Walsh T, Prescott RJ, et al.: A national study of plasma use in critical care: clinical indications, dose and effect on prothrombin time. Crit Care 2011; 15:R 108
14. Roback JD, Caldwell S, Carson J: Evidence based practice guidelines for plasma transfusion. Transfusion. 2010; 50:1227-1239
15. Buchta C, Felferning M, Hocker P, et al.: Stability of coagulation factors in thawed, solvent/detergent-treated plasma during storage at 4°C for 6 days. Vox Sang 2004; 87:182-186
16. Hellstern P: Fresh-Frozen Plasma, pathogen-reduced single-donor plasma or bio-pharmaceutical plasma? Transfus Apheres Sci 2008; 39:69-74
17. Chekrizova V, Murphy WG: Solvent-detergent plasma: use in neonatal patients, in adult and paediatric patients with liver disease and in obstetric and gynaecological emergencies. Transfus Med 2006; 16:85-91
18. Williamson LM, Llewelyn CA, Fisher NC, et al.: A randomized trial of solvent/detergent-treated and standard fresh-frozen plasma in the coagulopathy of liver disease and liver transplantation. Transfusion 1999; 39:1227-1234
19. De Silvestro G, Bagattella P, Tison T, et al.: Virus-inactivated plasma- Plasmasafe: a one year experience. Blood Transfus 2007; 5:134-142
20. Hellstern P, Solheim BG: The use of solvent/detergent treatment in pathogen reduction of plasma. Transfus Med Hemother 2011; 38:65-70
21. Biancofiore G, Critchley LA, Lee A, et al.: Evaluation of an uncalibrated arterial pulse contour cardiac output monitoring system in cirrhotic patients undergoing liver surgery. Br J Anaesth 2009; 102:47-54
22. Hett DA, Walker D, Pilkington SN, et al.: Sonoclot analysis. Br J Anaesth 1995; 75:771-776
23. Gastroenterology and Hepatology in Minnesota. Model for End-Stage Liver Disease (MELD). Available at http://www.mayoclinic.org/gi-rst/models.html
24. Haubelt H, Blome AH, Kiessling AH, et al.: Effects of Solvent/Detergent treated plasma and fresh frozen plasma on haemostasis and fibrinolysis in complex coagulopathy following open-heart surgery. Vox Sang 2002; 82:9-14
25. Ganter MT, Hofer CH: Coagulation monitoring: current techniques and clinical use of viscoelastic Point-of-care Coagulation devices. Anesth Analg 2008; 106:1366-1375
26. Bindi ML, Biancofiore GD, Consani G, et al.: Blood Coagulation monitoring during liver transplantation: Sonoclot Analysis and laboratory tests. Minerva Anestesiol 2001; 67:359-369
27. Biancofiore G, Bindi M, Esposito M, et al.: Sonoclot Analysis for the Point of Care Diagnosis of Hyperfibrinolysis During Orthotopic Liver Transplantation. Point of Care 2008; 7:23-29
28. Herbstreit F, Winter EM, Peters J, et al.: Monitoring of haemostasis in liver transplantation: comparison of laboratory based and point of care tests. Anaesthesia 2010; 65:44-49
29. ®). Anesth Analg 2002; 94:1127-1131
30. ®). Anesth Analg 2003; 96:1230-1231
31. Liumbruno GM, Sodini ML, Grazzini G: Recommendations from the Tuscan Transfusion System on the appropriate use of solvent/detergent-inactivated fresh-frozen plasma. Blood Transfus 2008; 6:25-36
32. De Jonge J, Groenland THN, Metselaar HJ, et al.: Liver transplantation, solvent-detergent treated plasma and antifibrinolytics. Anesth Analg 2003; 96:1231-1232
33. Kor DJ, Stubbs JR, Gajic O: Perioperative coagulation management-fresh frozen plasma. Best Pract Res Clin Anaesthesiol 2010; 24:51-64
34. Bischof D, Dalbert S, Zollinger A, et al.: Thromboelastography in the surgical patient. Min Anestesiol 2010; 76:131-137
35. Masato F, Nobuyuki U, Koiki H, et al.: Sonoclot Coagulation analysis: new bedside monitoring for determination of appropriate heparin dose during haemodialysis. Nephrol Dial Transplant 2002; 17:1457-1462